MedTrace Logo

A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain

NCT02381132 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2016-03-25

No results posted yet for this study

Summary

The purpose of this study is to explore the clinical characteristics oral MNK155 and Norco® 7.5mg/325mg when used for the treatment of moderate to severe post operative pain.

Conditions

  • Post Operative Pain

Interventions

DRUG

Norco 7.5mg/325

DRUG

MNK155

Sponsors & Collaborators

  • Mallinckrodt

    collaborator INDUSTRY

  • Neil Singla

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381132 on ClinicalTrials.gov